Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Cell Lysis And Fractionation Market?
There has been significant growth in the cell lysis and fractionation market in the past few years. The projections indicate a rise from $3.42 billion in 2024 to $3.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.9%. The historical growth rate can be associated with factors such as increased financing in life science studies, greater emphasis on individualized treatment, a high frequency of diseases, advancements in cell lysis and fractionation techniques, and an increased requirement for biopharmaceutical and biotechnological products.
The market size for cell lysis and fractionation is projected to experience robust growth in the forthcoming years, reaching $4.83 billion in 2029, with a CAGR of 7.0%. This surge over the forecast period can be credited to the rising emphasis on personalized medicine, elevated government research funding, an increased necessity for effective cell lysis and fractionation methodologies, and progress in genomics and proteomics technology, coupled with the escalating incidence of chronic and infectious ailments. The forecast period will also see predominant trends such as the sustained growth in the adoption of personalized medicine strategies, surging incorporation of automation and robotics in lysis and fractionation procedures, the broadening of applications in clinical diagnostics and drug creation, advancements in microfluidics, and lab-on-a-chip technologies for cell scrutiny, as well as an increasing focus on point-of-care and decentralized testing solutions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp
What Market Forces Are Contributing To The Growth Of The Cell Lysis And Fractionation Market?
The increased emphasis on personalized medicine is anticipated to boost the expansion of the cell lysis and fractionation markets. Personalized medicine, emerging as a new approach in the medical sector, utilizes a person’s genetic details to diagnose and treat diseases. This practice customizes clinical decisions and treatments based on individual patients’ characteristics, focusing predominantly on their genetic composition. Cell lysis and fractionation are pivotal in this approach as they enable the separation and analysis of specific subcellular components from patient samples, such as proteins, organelles, and nucleic acids. These elements allow medical experts and scientists to explore the molecular activities that cause diseases and formulate tailored treatments based on every patient’s unique molecular features. As an example, the Personalized Medicine Coalition (PMC), a US organization advocating the understanding and implementation of personalized medicine, reported in October 2022 that over 75,000 genetic testing products and 300 personalized medicines for various types of cancer, genetic rare disorders, and numerous chronic and infectious diseases will be available in the market. Thus, the escalating focus on personalized medicine is spearheading the growth of the cell lysis and fractionation markets.
Which Segmentation Factors Are Critical In The Cell Lysis And Fractionation Market Analysis?
The cell lysis and fractionationmarket covered in this report is segmented –
1) By Type: Mammalian Cells; Microbial Cells
2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation
3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies
Subsegments:
1) By Mammalian Cells: Adherent Mammalian Cells; Suspension Mammalian Cells; Primary Cells; Cell Lines
2) By Microbial Cells: Bacterial Cells; Yeast Cells; Fungal Cells; Algal Cells
How Are Global Trends Impacting The Development Of The Cell Lysis And Fractionation Market?
Leading firms in the cell lysis and fractionation market are striving for superiority by launching innovative solutions such as CGT (cell and gene therapy) viral vector lysis kits. These kits provide a more streamlined process for AAV (Adeno-associated virus) lysis, enhancing standard operating procedures, quality control, and safety, while also improving bioprocessing workflows. For example, in July 2023, QIAGEN, a German company known for its sample and assay technologies, unveiled its CGT Viral Vector Lysis Kit. This product enables accurate and uniform quantification of virus titers across various serotypes from cell lysates. This kit adds to QIAGEN’s burgeoning digital PCR offering for the biopharma sector, which already includes three QIAcuity Residual DNA Quantification Kits for the detection of residual host cell DNA, and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for AAV titer quantification.
Which Organizations Are At The Forefront Of The Cell Lysis And Fractionation Market?
Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report
Which Region Is Leading Innovation In The Cell Lysis And Fractionation Market?
North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp
Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2025, By The Business Research Company
Aircraft Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aircraft-pumps-global-market-report
Cell Counting Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report
Cellular M2M Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cellular-m2m-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model